FibroGen, Inc. (FGEN) DCF Valuation

Valoración de Fibrogen, Inc. (FGEN) DCF

US | Healthcare | Biotechnology | NASDAQ
FibroGen, Inc. (FGEN) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

FibroGen, Inc. (FGEN) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¡Obtenga información sobre su análisis de valoración de Fibrogen, Inc. (FGEN) utilizando nuestra sofisticada calculadora DCF! Con datos en tiempo real para (FGEN), esta plantilla de Excel le permite ajustar los pronósticos y supuestos, lo que permite un cálculo preciso del valor intrínseco de Fibrogen.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 256.6 176.3 235.3 140.7 147.8 135.6 124.4 114.1 104.7 96.0
Revenue Growth, % 0 -31.28 33.46 -40.19 4.99 -8.26 -8.26 -8.26 -8.26 -8.26
EBITDA -52.3 -164.3 -274.8 -282.8 -261.4 -112.1 -102.9 -94.4 -86.6 -79.4
EBITDA, % -20.39 -93.17 -116.78 -200.96 -176.92 -82.71 -82.71 -82.71 -82.71 -82.71
Depreciation 21.5 22.0 14.8 10.6 9.9 11.2 10.3 9.5 8.7 8.0
Depreciation, % 8.36 12.5 6.29 7.53 6.72 8.28 8.28 8.28 8.28 8.28
EBIT -73.8 -186.3 -289.6 -293.4 -271.3 -116.2 -106.6 -97.8 -89.8 -82.3
EBIT, % -28.75 -105.68 -123.08 -208.5 -183.64 -85.75 -85.75 -85.75 -85.75 -85.75
Total Cash 533.8 686.5 405.2 422.0 235.6 135.6 124.4 114.1 104.7 96.0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 153.7 41.9 25.4 16.3 41.1
Account Receivables, % 59.89 23.75 10.79 11.58 27.79
Inventories 6.9 16.5 31.0 40.4 41.6 22.3 20.4 18.7 17.2 15.8
Inventories, % 2.68 9.38 13.18 28.73 28.13 16.42 16.42 16.42 16.42 16.42
Accounts Payable 6.1 24.8 26.1 30.8 18.0 16.7 15.3 14.0 12.9 11.8
Accounts Payable, % 2.37 14.06 11.09 21.86 12.16 12.31 12.31 12.31 12.31 12.31
Capital Expenditure -5.8 -4.0 -30.2 -38.7 -2.5 -12.6 -11.6 -10.6 -9.7 -8.9
Capital Expenditure, % -2.25 -2.27 -12.83 -27.53 -1.7 -9.31 -9.31 -9.31 -9.31 -9.31
Tax Rate, % 0.91854 0.91854 0.91854 0.91854 0.91854 0.91854 0.91854 0.91854 0.91854 0.91854
EBITAT -74.1 -186.7 -290.0 -293.8 -268.8 -116.0 -106.4 -97.7 -89.6 -82.2
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -212.9 -47.8 -302.0 -317.6 -300.1 -94.6 -104.3 -95.7 -87.8 -80.5
WACC, % 8.8 8.8 8.8 8.8 8.74 8.79 8.79 8.79 8.79 8.79
PV UFCF
SUM PV UFCF -364.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -82
Terminal Value -1,209
Present Terminal Value -793
Enterprise Value -1,158
Net Debt 57
Equity Value -1,215
Diluted Shares Outstanding, MM 97
Equity Value Per Share -12.49

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real FibroGen (FGEN) financials.
  • Real-World Data: Historical data and forward-looking estimates (as displayed in the highlighted cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly observe how your inputs affect FibroGen’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and simplicity, complete with step-by-step instructions.

Key Features

  • Comprehensive FGEN Data: Pre-filled with FibroGen’s historical financials and future projections.
  • Flexible Input Options: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures as needed.
  • Interactive Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on user inputs.
  • Scenario Analysis: Develop various forecast scenarios to evaluate different valuation results.
  • Intuitive User Interface: Designed to be simple and structured for both professionals and newcomers.

How It Works

  • 1. Access the Template: Download and open the Excel file containing FibroGen, Inc.'s (FGEN) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures to fit your analysis.
  • 3. See Results in Real-Time: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
  • 5. Present with Assurance: Share professional valuation insights to bolster your decision-making process.

Why Choose This Calculator?

  • Accurate Data: Real FibroGen financials ensure reliable valuation results.
  • Customizable: Adjust key parameters like growth rates, WACC, and tax rates to match your projections.
  • Time-Saving: Pre-built calculations eliminate the need to start from scratch.
  • Professional-Grade Tool: Designed for investors, analysts, and consultants.
  • User-Friendly: Intuitive layout and step-by-step instructions make it easy for all users.

Who Should Use This Product?

  • Investors: Assess FibroGen, Inc.'s (FGEN) valuation prior to making investment decisions.
  • CFOs and Financial Analysts: Enhance valuation methodologies and evaluate financial forecasts.
  • Startup Founders: Understand the valuation strategies of established biopharmaceutical companies like FibroGen, Inc.
  • Consultants: Provide comprehensive valuation analyses and reports for clients in the healthcare sector.
  • Students and Educators: Utilize real-time data from FibroGen, Inc. (FGEN) to learn and teach valuation principles.

What the Template Contains

  • Pre-Filled Data: Includes FibroGen’s historical financials and forecasts.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze FibroGen’s profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

No products were found matching.